Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger Than 5 Years

Christopher Troeger, Ibrahim A. Khalil, Puja C. Rao, Shujin Cao, Brigette F. Blacker, Tahmeed Ahmed, George Armah, Julie E. Bines, Thomas G. Brewer, Danny V. Colombara, Gagandeep Kang, Beth D. Kirkpatrick, Carl D. Kirkwood, Jason M. Mwenda, Umesh D. Parashar, William A. Petri, Mark S. Riddle, A. Duncan Steele, Robert L. Thompson, Judd L. WalsonJohn W. Sanders, Ali H. Mokdad, Christopher J.L. Murray, Simon I. Hay, Robert C. Reiner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

227 Citations (Scopus)

Abstract

Importance: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years. Objectives: To examine the extent of rotavirus infection among children younger than 5 years by country and the number of deaths averted because of the rotavirus vaccine. Design, Setting, and Participants: This report builds on findings from the Global Burden of Disease Study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents. Models were used to estimate burden in data-sparse locations. Exposure: Diarrhea due to rotavirus infection. Main Outcomes and Measures: Rotavirus-associated mortality and morbidity by country and year and averted deaths attributable to the rotavirus vaccine by country. Results: Rotavirus infection was responsible for an estimated 128500 deaths (95% uncertainty interval [UI], 104500-155600) among children younger than 5 years throughout the world in 2016, with 104733 deaths occurring in sub-Saharan Africa (95% UI, 83406-128842). Rotavirus infection was responsible for more than 258 million episodes of diarrhea among children younger than 5 years in 2016 (95% UI, 193 million to 341 million), an incidence of 0.42 cases per child-year (95% UI, 0.30-0.53). Vaccine use is estimated to have averted more than 28000 deaths (95% UI, 14600-46700) among children younger than 5 years, and expanded use of the rotavirus vaccine, particularly in sub-Saharan Africa, could have prevented approximately 20% of all deaths attributable to diarrhea among children younger than 5 years. Conclusions and Relevance: Rotavirus-associated mortality has decreased markedly over time in part because of the introduction of the rotavirus vaccine. This study suggests that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection..

Original languageEnglish
Pages (from-to)958-965
Number of pages8
JournalJAMA Pediatrics
Volume172
Issue number10
DOIs
Publication statusPublished - Oct 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea among Children Younger Than 5 Years'. Together they form a unique fingerprint.

Cite this